Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from zidovudine to tenofovir or abacavir in HIV
2007-004372-39Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tenofovir, abacavir and zidovudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Aarhus University Hospital. Primary endpoints: Renal function over time and CD4+ T-cell count change. Started Sep 2007; status: terminated.
02
Drugs
tenofovirabacavirzidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-004372-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004372-39.